Fifth Third Bancorp’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-373
Closed -$1.27K 2533
2023
Q3
$1.27K Sell
373
-120
-24% -$408 ﹤0.01% 2436
2023
Q2
$3.62K Sell
493
-56
-10% -$412 ﹤0.01% 2288
2023
Q1
$5.69K Buy
549
+174
+46% +$1.8K ﹤0.01% 2293
2022
Q4
$4.43K Buy
375
+282
+303% +$3.33K ﹤0.01% 2249
2022
Q3
$2K Sell
93
-68
-42% -$1.46K ﹤0.01% 2416
2022
Q2
$5K Sell
161
-53
-25% -$1.65K ﹤0.01% 2217
2022
Q1
$9K Buy
214
+16
+8% +$673 ﹤0.01% 2088
2021
Q4
$9K Sell
198
-5,308
-96% -$241K ﹤0.01% 2125
2021
Q3
$276K Buy
5,506
+9
+0.2% +$451 ﹤0.01% 887
2021
Q2
$346K Sell
5,497
-3,094
-36% -$195K ﹤0.01% 801
2021
Q1
$798K Buy
8,591
+196
+2% +$18.2K ﹤0.01% 600
2020
Q4
$752K Sell
8,395
-917
-10% -$82.1K ﹤0.01% 603
2020
Q3
$962K Buy
9,312
+4,284
+85% +$443K 0.01% 525
2020
Q2
$398K Buy
5,028
+376
+8% +$29.8K ﹤0.01% 679
2020
Q1
$269K Sell
4,652
-1,822
-28% -$105K ﹤0.01% 753
2019
Q4
$349K Sell
6,474
-1,384
-18% -$74.6K ﹤0.01% 767
2019
Q3
$411K Sell
7,858
-355
-4% -$18.6K ﹤0.01% 688
2019
Q2
$397K Buy
8,213
+227
+3% +$11K ﹤0.01% 697
2019
Q1
$403K Sell
7,986
-269
-3% -$13.6K ﹤0.01% 672
2018
Q4
$489K Sell
8,255
-1,730
-17% -$102K ﹤0.01% 614
2018
Q3
$657K Sell
9,985
-2,163
-18% -$142K ﹤0.01% 603
2018
Q2
$613K Sell
12,148
-129
-1% -$6.51K ﹤0.01% 637
2018
Q1
$646K Buy
+12,277
New +$646K ﹤0.01% 602
2016
Q3
Sell
-15,200
Closed -$427K 2231
2016
Q2
$427K Sell
15,200
-3,149
-17% -$88.5K ﹤0.01% 747
2016
Q1
$667K Sell
18,349
-573
-3% -$20.8K 0.01% 637
2015
Q4
$757K Sell
18,922
-292
-2% -$11.7K 0.01% 608
2015
Q3
$547K Sell
19,214
-1,487
-7% -$42.3K 0.01% 712
2015
Q2
$682K Buy
20,701
+804
+4% +$26.5K 0.01% 660
2015
Q1
$572K Buy
19,897
+2,177
+12% +$62.6K 0.01% 723
2014
Q4
$483K Buy
17,720
+3,619
+26% +$98.6K ﹤0.01% 720
2014
Q3
$300K Sell
14,101
-5,416
-28% -$115K ﹤0.01% 860
2014
Q2
$438K Buy
19,517
+17,517
+876% +$393K ﹤0.01% 759
2014
Q1
$51K Buy
+2,000
New +$51K ﹤0.01% 1408